Treatment | N | 5-year RFS | P value | 5-year OS | P value |
---|---|---|---|---|---|
Radical surgery | 74 | 88.5 ± 4.4 % | 0.004 | 87.7 ± 4.8 % | 0.004 |
Alleviate surgery | 27 | 69.5 ± 9.7 % | 72.3 ± 9.7 % | ||
Radical surgery and chemotherapy with Rituximab | 44 | 93.8 ± 4.3 % | 0.302 | 93.3 ± 4.6 % | 0.333 |
Radical surgery and chemotherapy without Rituximab | 21 | 88.2 ± 7.8 % | 88.2 ± 7.8 % | ||
Alleviate surgery and chemotherapy with Rituximab | 16 | 92.9 ± 6.9 % | 0.002 | 91.7 ± 8.0 % | 0.001 |
Alleviate surgery and chemotherapy without Rituximab | 8 | 58.3 ± 18.6 % | 71.4 ± 17.1 % |